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Domoic acid (DomA) is a naturally occurring shellﬁsh toxin that can induce brain damage in mammalians. Neonates have shown
increased sensitivity to DomA-induced toxicity, and prenatal exposure has been associated with e.g. decreased brain GABA levels,
and increased glutamate levels. Here, we evaluated DomA-induced toxicity in immature and mature primary cultures of neurons
and glial cells from rat cerebellum by measuring the mRNA levels of selected genes. Moreover, we assessed if the induced toxicity
was mediated by the activation of the AMPA/KA and/or the NMDA receptor. The expression of all studied neuronal markers was
aﬀectedafterDomAexposureinbothimmatureandmaturecultures.However,thematureculturesseemedtobemoresensitiveto
the treatment, as the eﬀects were observed at lower concentrations and at earlier time points than for the immature cultures. The
DomA eﬀects were completely prevented by the antagonist of the AMPA/KA receptor (NBQX), while the antagonist of the NMDA
receptor (APV) partly blocked the DomA-induced eﬀects. Interestingly, the DomA-induced eﬀect was also partly prevented by
the neurotransmitter GABA. DomA exposure also aﬀected the mRNA levels of the astrocytic markers in mature cultures. These
DomA-induced eﬀects were reduced by the addition of NBQX, APV, and GABA.
1.Introduction
Mechanisms of domoic acid- (DomA-) induced toxicity have
been extensively investigated since an incident in 1987 in
Eastern Canada where several hundred people experienced
serious health problems after ingesting mussels. DomA-
induced toxicity has been studied mainly in adult animals,
and fetal developmental eﬀects have only been evaluated in a
limited number of studies. Based on these few experiments,
neonates have been shown to be more sensitive to DomA per
body weight than adults [1–5]. The reduced serum clearance
has been proposed as a contributing factor to their increased
vulnerability as well as greater access of DomA through the
undeveloped blood-brain barrier [1, 4]. DomA has also been
shown to cross the placenta and can reach the brain tissue of
thefetusandaccumulateintheamnioticﬂuid[6].Moreover,
a higher quantity of DomA remains in the milk as compared
to the plasma, and therefore, a new born baby can be more
exposed than the mother [7]. Prenatal exposure to DomA
has been associated with damage to neurons in diﬀerent
brain regions; however, the mechanisms of neurotoxicity is
not entirely clear. Some studies suggest that DomA decreases
levels of brain gamma-amino butyric acid (GABA) and
increases glutamate levels [8]. Moreover, DomA exposed
oﬀspring have shown neurobehavioral changes that have
persisted into adulthood [2, 5], such as an increase in2 Journal of Toxicology
response latency and in rate of habituation. On the contrary
to in vivo studies, in vitro studies have shown increased
DomA toxicity with increasing maturation of the CNS [9].
Therefore, the developmental neurotoxic eﬀects of DomA
need to be further studied to determine if this could be due
to diﬀerent toxic mechanisms, renal clearance, or increased
exposure.
DomA is structurally related to kainic acid (KA), which
is an analogue to the excitatory amino acid and neuro-
transmitter L-glutamate. Most likely, DomA activates the
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/KA
receptor (AMPA/KA-R), which induces increased levels of
intracellular Ca2+ which, in turn, causes glutamate release
that subsequently activates the N-methyl-D-aspartic acid
receptor (NMDA-R) [10, 11]. Activation of AMPA/KA-Rs
(direct) and NMDA-Rs (indirect) can cause apoptotic and
necrotic neuronal cell death [12, 13] .T h em o d eo fn e u r o n a l
cell death, apoptotic or necrotic, in pure neuronal cultures
seems to depend on the concentrations of DomA, as a low
concentration (0.1μM) induces apoptosis mainly through
AMPA/KA-Rs, and a high concentration (10μM) induces
necrosis also through glutamate release and secondary
activation of NMDA-R [14]. In addition, the exposure time
has also been identiﬁed as an important factor that might
increase the DomA-induced toxicity [9].
Furthermore, a few studies have suggested involvement
of glial cells that could enhance the DomA-induced neuro-
toxicity [15, 16]. Some studies have reported that exposure
of astrocytic cultures to DomA did not induce any cell death
[14, 15], but it changed the glia function, as inhibition of the
glutamate uptake was observed [15]. The mechanism behind
the inhibition of glutamate uptake is not yet known but
could be a secondary eﬀect related to decreased levels of ATP,
glutamate-receptor activation, intracellular acidiﬁcation, or
free-radical formation [15]. Moreover, there are to our
knowledge hardly any studies performed in mixed glial-
neuronal cultures, which are the most relevant models to
in vivo situations. The interaction between glia and neurons
is certainly important especially during development of the
brain and could play an important role in DomA-induced
toxicity both in in vivo and in in vitro systems.
In this study, we have used mixed neuronal-glial primary
cultures of CGCs to determine the mechanisms of DomA-
induced toxicity in both immature and mature cultures.
As a main endpoint for toxicity evaluation, we have used
gene expression, as in our previous studies it has been
shown that the mRNA levels of diﬀerent cell-type-speciﬁc
markers (neuronal and astrocytic) at various time points
of cell development and maturation could be a useful
tool to detect developmental neurotoxicants [17, 18]. The
purpose of this study was to determine if the selected genes
identiﬁed as speciﬁc markers for glial and neuronal cells
could serve as an endpoint for in vitro assessment of DomA-
induced toxicity. Furthermore, we evaluated if developing
(immature) and mature mixed neuronal-glia cultures of
primary rat cerebellar granule cells (CGCs) were aﬀected in
diﬀerent ways by domoic acid exposure. Indeed, the mRNA
expressions of the neuronal and astrocytic markers were
altered after the exposure to DomA in both immature and
mature cultures. Interestingly, the mature cultures seemed to
be more vulnerable than the immature ones, probably due
to the higher expression of NMDA and AMPA receptors.
In both cell culture models, the DomA eﬀect was mainly
mediated through the AMPA/KA-R. However, not only
the antagonist for AMPA/KA-R, but also antagonist of the
NMDA-R and neurotransmitter GABA reduced the DomA-
induced changes.
2.MaterialsandMethods
2.1. Chemicals and Reagents. Reagents for cell culture were
purchased from Gibco Invitrogen (Milano, Italy); DMEM,
Fetal Bovine Serum, Horse Serum, L-Glutamine, Gentam-
icin, Versene, Hepes and from Sigma-Aldrich (Milano,
Italy); Poly-L-Lysine, D (+) Glucose, Potassium chloride,
domoic acid, 1, 2, 3, 4-tetrahydro-6-nitro-2, 3-dioxo-ben-
zo[f]quinoxaline-7-sulfonamide (NBQX), ((2R)-amino-5-
phosphonovaleric acid (APV) and GABA.
2.2. Primary Culture of Rat Cerebellar Granule Cells (CGCs).
The primary cultures of cerebellar granule cells (CGCs)
were prepared from 7-day old Wistar rat pups as described
previously [19]. The cerebella were dissociated in Versene
solution (1:5000) and plated at 0.25 × 106 cells/cm2 in
12- or 96-well Costar plates coated with poly-L-lysine
(0.01% diluted 1:10 (v/v) in sterile MilliQ water). Cultures
were maintained in DMEM supplemented with 5% heat
inactivated horse serum, 5% heat inactivated fetal bovine
serum, 13mM glucose, 0.5mM HEPES buﬀer, 2mM L-
glutamine, 25mM KCl and 10μg/mL gentamicin. Cells were
maintained at 37◦C in a humidiﬁed atmosphere of 5% CO2.
The medium of CGCs was not changed throughout the
whole experimental period, as these cells have to be cultured
in self-conditioned medium.
2.3. Domoic Acid Treatment of CGCs. The concentrations
of domoic acid were chosen based on preliminary range-
ﬁnding experiments, where wide ranges of concentrations
were tested using the Alamar Blue (AB) (resazurin, Sigma,
Milano, Italy) cell viability assay (data not shown). In the
ﬁnal experiments three noncytotoxic concentrations (5, 10,
and 20μM) were selected based on the AB assay results.
Immature cultures were exposed to domoic acid twenty-
four hours after isolations for 3 or 10 days, to cover critical
developmental processes at various stages of cell maturation.
Mature cultures were exposed to DomA for 3 or 10 days
at 7 DIV, when the culture is considered mature [20]. To
determine whether the presence of domoic acid inﬂuenced
the selected gene expression, cell samples were prepared for
quantitative real-time PCR analysis before exposure (1 DIV)
and after 3 or 10 days of DomA exposure in both immature
mature cultures.
2.4. Antagonists or Agonist Treatment of CGCs. Both imma-
ture and mature control cultures (nonexposed) and cultures
exposed to 20μM domoic acid were pretreated with the
AMPA/KA-R antagonist (NBQX, 20μM), NMDA-R antago-
nist (APV, 100μM), or the neurotransmitter GABA (10μM).
The cultures were pretreated with the antagonists or GABAJournal of Toxicology 3
at1DIV(immaturecultures)or7DIV(maturecultures)and
thereafter added every third day of treatment. To determine
whether the presence of the antagonists or GABA could
prevent the domoic acid induced toxicity as measured by
gene expression, mRNA was extracted from treated and
nontreated cultures for quantitative real-time PCR analysis
after 3 or 10 days of exposure to DomA of immature and
mature cultures.
2.5. Assessment of Cell Viability Using Alamar Blue. Cell
viability was determined after 3 and 10 days of exposure
to DomA using the AB (resazurin) assay [21]. The blue
colored indicator dye resazurin is reduced into ﬂuorescent
resoruﬁn by red-ox reactions in viable cells. Resazurin (10μL
of 100μMs t o c k )i nH a n k ’ sb u ﬀered salt solution was added
directly to the 96-well plates, without removing the medium
(100μL). The plates were incubated for 2h at 37◦C, 5%
CO2. After incubation, the ﬂuorescence of the resazurin
metabolite, resoruﬁn was measured at 530nm/590nm (exci-
tation/emission) in a multiwell ﬂuorometric reader (Fluo-
roskan Ascent, Labsystem, Helsinki, Finland).
2.6. RNA Puriﬁcation, Reverse Transcription, and Quanti-
tative Real-Time PCR. Cell samples for analysis of mRNA
expression were lysed, and total RNA extraction was per-
formed according to the manufacturer’s protocol of RNeasy
Mini Kit (Qiagen, Milan, Italy). Possible contamination
with DNA was removed by digestion using an RNase-
free DNase set (Qiagen). RNA concentration and protein
contamination were assessed spectrophotometrically (Bio-
p h o t o m e t e r ;E p p e n d o r f ,M i l a n ,I t a l y ) .R e v e r s et r a n s c r i p t i o n
was performed as follows: 500ng RNA was incubated with
2.5mM PCR Nucleotide Mix (Promega, Milan Andorra,
Italy) and 12.5μg/mL random primers (Promega) for 5min
at 65◦C using a Perkin-Elmer Geneamp PCR system 9600.
Subsequently, 2 units/μL RNaseOut inhibitor (Invitrogen),
10 units/μL M-MLV reverse transcriptase (Promega) was
added with the respective M-MLV buﬀer (Promega), and the
samples were incubated for 10min at 25◦C for annealing,
60min at 37◦C for cDNA synthesis and 15min at 70◦Cf o r
inactivation of enzymes.
An AbiPrism 7000 sequence detector system in con-
junction with TaqMan Universal PCR Master Mix and
TaqMan Real-Time PCR Assays-on-Demand (Applera
Italia, Monza, Italy) was used for investigating the gene
expression and the house keeping gene according to the
manufacturer’s protocol. The primers used were 18S
ribosomal RNA (18S rRNA, Hs99999901 s1) (TaqMan Gene
Expression Assays ID), neuroﬁlament, light polypeptide
68kDa (Nﬂ, Rn00582365 m1), neuroﬁlament, heavy
polypeptide 200kDa (Nefh, Rn00709325 m1), ionotropic
glutamate receptor N-methyl D-aspartate 1 (GRIN1,
Rn00433800 m1), ionotropic glutamate receptor AMPA1
(alpha 1) (Gria1, Rn00709588 m1), gamma-amino butyric
acidAreceptordelta(Gabrd,Rn01517015 g1),glialﬁbrillary
acidic protein (Gfap, Rn00566603 m1), S100 protein,
beta polypeptide (S100β, Rn00566139 m1), and nestin
(Nes, Rn00564394 m1). Relative RNA quantiﬁcation was
performed using the comparative CT method, normalizing
the data to a standard calibrator (a mixture of samples
from the diﬀerent time points of the cell proliferation and
diﬀerentiation), and to the 18S rRNA content [22].
2.7. Statistical Analysis. The GraphPad Prism 5.0 (GraphPad
software, San Diego, Calif, USA) program was used for
statistical analyses. All data given are means of three inde-
pendent experiments performed in duplicates ± standard
error of the mean (S.E.M.). One-way ANOVA and posttest
(0.05) were performed to assess diﬀerences between diﬀerent
time points, and two-way ANOVA and posttest (0.05) were
performed to assess diﬀerences between treated and control
in the quantitative real-time PCR experiments. All data were
log-transformed to achieve Gaussian distribution. Statistical
signiﬁcance was indicated as follows +P<0.05, ++P<0.01
and +++P<0.001 (3 days versus 10 days) and ∗P<0.05,
∗∗P<0.01 and ∗∗∗P<0.001 (treated versus control).
3. Results
3.1. Domoic Acid Exposure Downregulated the mRNA Levels
of the Neuronal Cytoskeleton Proteins (NF-68 and NF-200) in
both Immature and Mature Cultures. In order to determine
if immature mixed neuronal-glial primary cultures of CGCs
were more sensitive to domoic acid toxicity than mature
ones, both cultures were exposed to the same range of sub-
cytotoxic concentrations of domoic acid (5, 10 and 20μM)
up to 10 days at 1 DIV (immature) or at 7 DIV (mature).
These concentrations were not cytotoxic as conﬁrmed by cell
viability assay (data not shown). Two cytoskeleton proteins
were selected, the neuroﬁlament 68 (NF-68) that is the ﬁrst
to be expressed during the initial neurite outgrowth and
neuroﬁlament 200 (NF-200) that is expressed later and is
recognized as a marker of the mature neuronal network. In
control (nontreated) cultures, a signiﬁcant increase in the
mRNA levels for both NF-68 and NF-200 was observed with
timeintheimmatureculturesbetween3and10days(Figures
1(a) and 1(c)), while in the mature cultures the mRNA levels
of the neuroﬁlaments remained stable (Figures 1(b) and
1(d)).
3.1.1. Eﬀects of Domoic Acid
Immature Cultures. The prolonged exposure for 10 days to
DomAatallstudiedconcentrations(5,10and20μM)caused
a signiﬁcant downregulation of both the NF-68 mRNA (by
41 ± 4%, P<0.05; 38 ± 7%, P<0.05; 38 ± 5%, P<0.05)
andtheNF-200mRNAlevel(by50 ±6%,P<0.01;59 ±6%,
P<0.001; 47 ± 7%, P<0.01), when compared to control
(Figures1(a)and1(c)).Furthermore,themRNAlevelofNF-
200 was decreased (by 39 ± 12%, P<0.05) already after 3
days exposure (4 DIV) to 20μM domoic acid (Figure 1(c)).
Mature Cultures. Exposure to the highest concentration of
DomA (20μM) for 3 days induced a signiﬁcant downregula-
tion of the mRNA level of NF-68 (by 49 ± 15%, P<0.05)
as compared to control cultures (Figure 1(b)). The same
concentration (20μM) decreased the NF-68 mRNA level
further(by72 ±7%,P<0.001)aftertheprolongedexposure
for 10 days (Figure 1(b)).4 Journal of Toxicology
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Figure 1: Changes in the mRNA levels of NF-68 and 200 in primary cultures of CGCs exposed to domoic acid (5μM, 10μM, and 20μM)
at 1 DIV (immature cultures) or at 7 DIV (mature cultures) for 3 or 10 days. Note the signiﬁcant downregulation of (a) NF-68 in immature
cultures after 10 days of exposure, (b) NF-68 in mature cultures, (c) NF-200 in immature cultures, and (d) NF-200 in mature cultures. Gene
expression levels were normalized to the standard calibrator, the housekeeping gene 18S rRNA and the mRNA expression at 1 DIV. Data
represent mean ± S.E.M. of three independent experiments performed in duplicates. +P<0.05 ++P<0.01 +++P<0.001 comparing control
cultures at 3 and 10 days. ∗P<0.05 ∗∗P<0.01 ∗∗∗P<0.001 comparing treated to control (untreated) cultures.
In the case of NF-200, mRNA levels were also signiﬁ-
cantly decreased (by 65 ± 10%, P<0.01) after exposure
to 20μM domoic acid when compared to control cultures
already after 3 days of exposure (Figure 1(d)). However,
after prolonged (10 days) exposure, the decrease was already
observed at the lower concentration (10μM) by 60 ± 9%
(P<0.05). (Figure 1(d)). The obtained results show that
the neuronal cytoskeleton proteins are aﬀected by DomA
exposure in both immature and mature cultures of CGCs.
However, the mature cultures seem to be more sensitive,
since the eﬀects were observed at an earlier time point
compared to the immature ones.
3 . 2 .T h em R N AE x p r e s s i o no ft h eN M D A -a n dG A B A A-R
Was Decreased by Domoic Acid While the mRNA Level of
the AMPA-Receptor Was Unchanged. To determine whether
the process of neuronal maturation was aﬀected by DomA
exposure, subunits of ionotropic receptors of the main
excitatory neurotransmitter glutamate (AMPA- and NMDA-
R) and a subunit of the GABAA receptor, the main inhibitoryJournal of Toxicology 5
neurotransmitter, were investigated. Subunits of the recep-
tors were selected based on previous studies [17]t oc o v e r
both early (NMDA-R) and later (GABAA-R and AMPA-R)
expressed genes.
Based on the published studies, it is not clear whether
DomA toxicity is mediated only by the AMPA-receptor or
if the NMDA receptor could also play a role. In control
(nontreated) cultures, a signiﬁcant increase of the mRNA
levels of both the AMPA-R (Figure 2(c))a n dG A B A A-R
(Figure 2(e)) was observed between 3 and 10 days in the
immature cultures, while the mRNA level remained stable in
the mature cultures (Figures 2(d) and 2(f)). The mRNA level
of the NMDA-R did not change during this time interval in
eitherimmatureormaturecontrolcultures(Figures2(a)and
2(b)).
3.2.1. Eﬀects of Domoic Acid
Immature Cultures. After 10 days of exposure to the highest
concentration of DomA (20μM), the mRNA level of the
NMDA-R signiﬁcantly decreased (by 30 ± 6%, P<0.05) as
compared to control cultures (Figure 2(a)). The same DomA
concentration induced a signiﬁcant downregulation of the
mRNA level of the GABAA-R (by 49 ± 6%, P<0.001) after
3d a y so fe x p o s u r e( Figure 2(e)). However, after prolonged
treatmentof 10 days, no signiﬁcanteﬀectwasobservedatthe
mRNA level of the GABAA-R. Interestingly, the mRNA level
of the AMPA-R was not changed after the DomA treatment
at any time points (3 and 10 days) (Figure 2(c)).
Mature Cultures. In our mixed neuronal-glial cell culture
model, the mRNA level of the NMDA-R seemed to be more
aﬀected in the mature cultures compared with the immature
ones. 3 days of exposure to 20μM DomA signiﬁcantly
decreased the mRNA level of this receptor (by 45 ± 15%
(P<0.05) (Figure 2(b)), while no eﬀect was observed in the
immature cultures (Figure 2(a)). 10 days exposure to 20μM
DomA further decreased the mRNA level of the NMDA-R
(by 69 ± 7%, P<0.01) (Figure 2(b)). The mRNA level of
the GABAA-R was reduced only after 10 days exposure to the
highest concentration of 20μMD o m A( 5 4± 11%, P<0.05)
(Figure 2(f)). However, no eﬀect was observed at the mRNA
level of the AMPA-R (Figure 2(d)).
These results show that the mRNA levels of the NMDA-
and GABAA-R, but not the mRNA level of the AMPA-R,
were downregulated in both immature and mature cultures
exposed to domoic acid, however, in diﬀerent ways. Once
again, the mature cultures seem to be more sensitive to
DomA as the observed eﬀects were stronger and took place
earlier especially in the case of the mRNA of the NMDA-R
(Figures 2(a) and 2(b)).
3.3. Domoic Acid Exposure Aﬀected the mRNA Levels of the
Astrocytic Markers (GFAP and S100β) in Mature but not
in Immature Cultures. During development of the central
nervous system the astrocytes play an important role, as
theyreleasetrophicfactors,guideaxons,inﬂuencefunctional
plasticity of synapses, and protect neurons from oxidative
stress[23–26].Forthispurpose,wehavestudiedtwomarkers
of mature astrocytes, the intermediate ﬁlament GFAP and
the zinc-calcium-binding protein S100β. In control cultures,
the mRNA levels of GFAP and S100β signiﬁcantly increased
with time (between 3 and 10 days) in immature cultures
(Figures 3(a) and 3(c)). In mature cultures the mRNA level
of GFAP continued to increase, however, not signiﬁcantly
(Figure 3(b)),whiletheS100β remainedstable(Figure 3(d)).
Moreover, to cover earlier neural developmental stages,
nestin, a marker for neural precursor cells, was studied.
Nestin is a cytoskeleton protein mainly expressed in neural
precursor cells but it has also been reported to be re-
expressed in activated astrocytes as a response to neuronal
damage [27–29]. The mRNA expression of nestin was stable
over the studied time points in both immature and mature
control cultures (Figures 3(e) and 3(f)).
3.3.1. Eﬀects of Domoic Acid
Immature Cultures. Exposure to DomA up to 20μM did not
induce any signiﬁcant changes at the mRNA levels for the
astrocytic markers GFAP and S100β (Figures 3(a) and 3(c))
or the neural precursor marker nestin (Figure 3(e)).
Mature Cultures. Interestingly, exposure of mature cultures
to the highest concentration of DomA (20μM) for 10
days induced a signiﬁcant downregulation of the mRNA
expression of the astrocytic marker GFAP (by 50 ± 3%;
P<0.05) (Figure 3(b)), as compared to control cultures. In
contrast, the mRNA level of S100β was upregulated after the
prolonged exposure (10 days) at all studied concentrations
(5, 10, and 20μM) by 53 ± 9% (P<0.01), 45 ± 13% (P<
0.05) and 34 ± 13% (P<0.05), respectively, (Figure 3(d)).
Furthermore, the mRNA levels of nestin in mature
cultures signiﬁcantly increased after 10 days exposure to 10
and 20μM DomA (up to 123 ± 40%, P<0.05 and 98 ±
24%, P<0.05, resp.) (Figure 3(f)). The increase in the
mRNA expression of nestin could be due to proliferation
of precursor cells, higher expression of nestin per cell,
or, and most likely, because of re-expression of nestin in
astrocytes that probably became activated in response to
DomA-induced neurotoxicity.
The obtained results indicate that mature astrocytes
were aﬀected by the exposure to domoic acid, as the gene
expression of the various astrocytic markers was down-
(GFAP) or upregulated (S100β and nestin). There were no
observed changes in the immature cultures.
3.4. The AMPA/KA Receptor Mediates DomA-Induced Neu-
rotoxicity in both Immature and Mature Cultures of CGCs.
In order to evaluate if the observed toxic eﬀects induced by
domoic acid were mediated by activation of the AMPA/KA-
and/or the NMDA receptor, the cultures were treated with
competitive antagonists (NBQX and APV, resp.) alone or in
combination with the highest tested concentration of DomA
(20μM). Additionally, to determine whether increased levels
of the inhibitory neurotransmitter GABA could prevent
domoic acid-induced excitotoxicity, as it has been proposed
in in vivo studies [8], the cultures were pretreated with this
neurotransmitter. The studied concentrations of the NMDA6 Journal of Toxicology
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Figure 2:ChangesinthemRNAlevelsofneuralreceptorsinprimaryculturesofCGCsexposedtodomoicacid(5μM,10μM,and20μM),at
1 DIV (immature cultures) or at 7 DIV (mature cultures) for 3 or 10 days. Note the signiﬁcant downregulation of (a) NMDA-R in immature
cultures after 10 days of exposure (20μM), (b) NMDA-R in mature cultures, (e) GABAA-R in immature cultures after 3 days of exposure
(20μM), and (f) GABAA-R in mature cultures after 10 days of exposure (20μM). There were no changes for (c) AMPA-R in immature
cultures and (d) AMPA-R in mature cultures. Gene expression levels were normalized to the standard calibrator, the housekeeping gene
18S rRNA and the mRNA expression at 1 DIV. Data represent mean ± S.E.M. of three independent experiments performed in duplicates.
+P<0.05 ++P<0.01 +++P<0.001 comparing control cultures at 3 and 10 days. ∗P<0.05 ∗∗P<0.01 ∗∗∗P<0.001 comparing treated to
control (untreated) cultures.Journal of Toxicology 7
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Figure 3: Changes in the mRNA levels of astrocytic and neural precursor markers in primary cultures of CGCs exposed to domoic acid
(5μM, 10μM, and 20μM) at 1 DIV (immature cultures) or at 7 DIV (mature cultures) for 3 or 10 days. There were no observed changes
for (a) GFAP in immature cultures, (c) S100β in immature cultures, and (e) nestin expression in immature cultures. However, there was
a signiﬁcant decrease of (b) GFAP mRNA levels in mature cultures after 10 days of exposure (20μM) and increase of (d) S100β mRNA
expression in mature cultures after 10 days of exposure and (f) nestin mRNA expression in mature cultures after 10 days of exposure. Gene
expression levels were normalized to the standard calibrator, the housekeeping gene 18S rRNA and the mRNA expression at 1 DIV. Data
represent mean ± S.E.M. of three independent experiments performed in duplicates. +P<0.05 ++P<0.01 +++P<0.001 comparing control
cultures at 3 and 10 days. ∗P<0.05 ∗∗P<0.01 ∗∗∗P<0.001 comparing treated to control (untreated) cultures.8 Journal of Toxicology
and AMPA/KA receptor antagonists (100μM of APV and
20μM of NBQX) and the agonist (10μM of GABA) were
selected based on ﬁndings from the literature [9, 14, 30].
These concentrations of APV, NBQX, and GABA did not
induce any changes in the mRNA levels of studied genes in
the control cultures (Figures 4–6).
3.5. Antagonists of the AMPA/KA- but Not of the NMDA-R
PreventedtheDomoicAcidInducedDecreaseofNF-68and
NF-200 mRNA Levels
3.5.1.ImmatureCultures. Exposureoftheimmaturecultures
to 20μM domoic acid for 10 days signiﬁcantly decreased
the mRNA levels of NF-68 (by 54 ± 13%; P<0.01)
(Figure 4(a)) compared to control cultures. Pretreatment
with the AMPA/KA-R antagonist (20μMN B Q X )c o m p l e t e l y
prevented this eﬀect, as the expression of the mRNA of
NF-68 was at the same level as in the control cultures
(Figure 4(a)). In contrast, pretreatment with the NMDA-R
antagonist (100μM APV) did not have any eﬀect, and the
addition of GABA (10μM) partly prevented domoic acid-
induced changes at the mRNA levels of NF-68 (Figure 4(a)).
Similar results were observed in the case of the NF-200
mRNA, levels. Domoic acid alone downregulated the gene
expression by 67 ± 2% (P<0.001) after 3 days of exposure
and by 71 ± 10% (P<0.001) after 10 days compared
to the control cultures (Figure 4(c)). The presence of the
AMPA/KA-R (NBQX) antagonist completely prevented the
DomA-induced changes of the NF-200 mRNA since it was
brought up to the control level. Interestingly, the antago-
nist for the NMDA-R (APV) blocked the DomA-induced
decrease of the NF-200 mRNA after 3 days of exposure but
not after prolonged treatment (up to 10 days) (Figure 4(c)).
Treatment with GABA did not have any eﬀect on the domoic
acid induced downregulation of the NF-200 mRNA levels
(Figure 4(c)).
3.5.2. Mature Cultures. In mature cultures, the exposure to
20μM domoic acid alone downregulated the mRNA levels
of NF-68 by 39 ± 7% (P<0.01) after 3 days of exposure
and by 41 ± 3% (P<0.01) after 10 days (Figure 4(b)).
When the AMPA/KA-R antagonist (NBQX) was present, the
obse rv edc hangesw e r ep r ev e nt ed(Figure 4(b)).TheNMDA-
R antagonist (APV) did not have any eﬀect as the mRNA
expression of NF-68 was still decreased (by 33 ± 9% after
3 days of exposure and by 45 ± 7%, P<0.01 after 10 days)
as compared to control cultures (Figure 4(b)). Interestingly,
the increased levels of the neurotransmitter GABA prevented
the domoic acid eﬀect, as the mRNA expression of NF-68
was at the same level as in the control cultures (Figure 4(b)).
The mRNA level of NF-200 was downregulated by the 20μM
DomA treatment in mature cultures after 3 days of exposure
(by 49 ± 1%, P<0.001) and after 10 days (by 62 ± 3%, P<
0.001) (Figure 4(d)). Pretreatment with NBQX prevented
this eﬀect, while the changes remained in the presence of
APV (the mRNA expression of NF-200 was still decreased)
(Figure 4(d)). GABA reduced the eﬀects of DomA, as the
mRNA levels of NF-200 decreased less (by 34 ± 6%, P<
0.05)after3and10daysofexposure(by28 ±10%,P<0.05)
compared to treatment with domoic acid alone (by 49 ± 1%,
P<0.001 after 3 days and by 62 ± 3%, P<0.001 after 10
days) (Figure 4(d)).
The obtained results indicate that DomA-induced eﬀects
were mediated mainly by the AMPA/KA-R, as its antag-
onist NBQX could prevent the decrease observed at the
mRNA levels for NF-68 and NF-200 in both immature
and mature cultures. Furthermore, the inhibitory neuro-
transmitter GABA could also be involved, since increased
levels partially protected the DomA-induced neurotoxicity,
especially in the case of mature cultures.
3.6. The AMPA/KA-R Antagonist Prevented Domoic Acid-
Induced Decrease of NMDA- and GABAA-R mRNA Levels
3.6.1. Immature Cultures. Domoic acid exposure (20μM)
alone in immature culturesdecreased the mRNAlevels of the
NMDA-Rby46 ±2%(P<0.05)after3daysofexposureand
by 52 ± 12% (P<0.01) after 10 days compared to control
cultures (Figure 5(a)). NBQX (antagonist for the AMPA/KA-
R)completelypreventedtheobserveddecreaseoftheNMDA
mRNA expression, while the addition of GABA and APV
(NMDA-R antagonist) reduced the eﬀect.
Domoic acid exposure downregulated the GABAA-R
mRNA expression by 59 ± 2% (P<0.01) after 3
days of exposure versus control (Figure 5(c)). Interestingly,
this eﬀect was completely prevented by NBQX and APV
(Figure 5(c)) indicating that both receptors, AMPA/KA-R
and NMDA-R, were involved. However, increased levels of
GABA itself did not have any eﬀect, as the GABAA-R mRNA
levels were still downregulated (by 47 ± 2%, P<0.05) after
3d a y so fe x p o s u r e( Figure 5(c)).
3.6.2. Mature Cultures. Exposure of mature cultures to
20μM DomA-induced a signiﬁcant downregulation of the
NMDA-R mRNA levels at both time points 3 days of
exposure (by 43 ± 1%, P<0.01) and 10 days of exposure
(by 58 ± 3%, P<0.001) (Figure 5(b)). These eﬀects were
blocked by the AMPA/KA-R antagonist (NBQX), and the
neurotransmitter GABA (Figure 5(b)), while the NMDA-R
antagonist (APV) did not have any eﬀect.
The mRNA expression of the GABAA-R was also signif-
icantly decreased by 20μMD o m A( 5 1± 1%, P<0.001)
a f t e r1 0d a y so fe x p o s u r e( Figure 5(d)). This decrease was
prevented by NBQX and by GABA treatment (Figure 5(d)).
However, the treatment with APV did not have any eﬀect,
as the expression of the GABAA-R was still signiﬁcantly
decreased (Figure 5(d)).
These results show that the AMPA/KA-R played a
crucial role in DomA-induced toxicity, as the antagonist
(NBQX) completely prevented the observed decrease in
mRNA expression of the NMDA- and GABAA-R in both
immature and mature cultures. Moreover, the NMDA-R was
less involved, as its antagonist (APV) did not fully protect
against the observed eﬀects (Figure 5). Interestingly, the
neurotransmitter GABA could protect against the domoic
acid-induced toxicity in the mature cultures (Figures 5(b)
and 5(d)) but not in the immature ones (Figures 5(a) and
5(c)). This could be due to the fact that the immatureJournal of Toxicology 9
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Figure 4: Changes in the mRNA levels of NF-68 and 200 in primary cultures of CGCs exposed to 20μM domoic acid alone or in
combination with antagonists for the AMPA-R (NBQX, 20μM), NMDA-R (APV, 100μM) or the neurotransmitter GABA (10μM) at 1
DIV (immature cultures) or at 7 DIV (mature cultures) for 3 or 10 days. Note that NBQX but not APV prevent the domoic acid-induced
downregulation of (a) NF-68 in immature cultures, (b) NF-68 in mature cultures, (c) NF-200 mRNA expression in immature cultures,
and of (d) NF-200 in mature cultures. Gene expression levels were normalized to the standard calibrator, the housekeeping gene 18S
rRNA and the mRNA expression at 1 DIV. Data represent mean ± S.E.M. of three independent experiments performed in duplicates.
∗P<0.05 ∗∗P<0.01 ∗∗∗P<0.001 comparing treated to control (untreated) cultures.
cultures could express lower levels of the functional GABA
receptors at early time points in comparison to mature
cultures.
3.7. Domoic Acid Induced Alternations at the mRNA Level of
GFAP,S100β,andNestinWerePartlyPreventedbyNBQX,
APV or GABA
3.7.1. Immature Cultures. Since in the case of immature
cultures DomA did not induce any eﬀects at the mRNA
levels of the astrocytic markers, GFAP, and S100β or the
neural precursor cell marker nestin, no further studies were
performed with the antagonists of NMDA-R, AMPA/KA-R
or with the neurotransmitter GABA.
3.7.2. Mature Cultures. T h em a t u r ec u l t u r e se x p o s e dt o
domoic acid (20μM) alone showed a signiﬁcant downreg-
ulation of the mRNA levels of GFAP (by 48 ± 2%, P<0.01)
compared to control after 10 days of exposure (Figure 6(a)).
These toxic eﬀects were blocked by NBQX but neither by
APV nor the neurotransmitter GABA, as the GFAP expres-
sion was still decreased after 10 days of exposure (by 44 ±
9%; P<0.05 after APV treatment and by 46 ± 2%; P<0.05
in the presence of GABA) (Figure 6(a)). In contrast to GFAP,
20μM DomA exposures induced signiﬁcant upregulation by
63 ± 18% (P<0.001) of the S100β mRNA levels after 10
days of exposure (Figure 6(b)). Interestingly, this eﬀect was
completely blocked by the pretreatment of NBQX, APV, or
GABA (Figure 6(b)).
Similarly to S100β, the mRNA expression of nestin
(neural precursor cell marker) was signiﬁcantly increased
(by 71 ± 12% (P<0.001) after 10 days of exposure
to 20μM domoic acid when compared to control cultures
(Figure 6(c)). This increase is likely due to re-expression
of nestin in activated astrocytes. Both NBQX and APV
blocked this eﬀect as no diﬀerences in comparison to control
cultures were observed (Figure 6(c)). The increased level of
neurotransmitter GABA reduced the toxicity, as the eﬀect
was less signiﬁcant (26% ± 3%; P<0.05) when compared
to cultures exposed only to DomA (71% ± 12%, P<0.001)
(Figure 6(c)).
Our results suggest that the various toxic eﬀects induced
by domoic acid in neuronal and glial cells of mixed
primary culture of CGCs seem to be mediated by diﬀerent
receptors. The changes in mRNA expression of the neuronal
markers(NF-68and−200,andNMDAandGABAreceptors)
could mainly be prevented by NBQX, suggesting that the
AMPA/KA receptor was involved. The eﬀects observed at
the level of astrocytic markers S100β and nestin (possibly
as a marker of reactive astrocytes) could be prevented by
both NBQX and APV, indicating that both AMPA/KA- and
NMDA- receptors could play a role in DomA-induced toxic-
ity.However,morestudiesshouldbeperformedtodetermine10 Journal of Toxicology
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Figure 5: Changes in the mRNA levels of neural receptors in primary cultures of CGCs exposed to 20μM domoic acid alone or in
combination with antagonists for the AMPA-R (NBQX, 20μM), NMDA-R (APV, 100μM), or the neurotransmitter GABA (10μM) at 1
DIV (immature cultures) or at 7 DIV (mature cultures) for 3 or 10 days. Note that NBQX completely and APV and GABA partly prevent
the domoic acid induced downregulation of (a) NMDA-R in immature cultures, (b) NMDA-R in mature cultures, (c) GABAA-R mRNA
expression in immature cultures, and of (d) GABAA-R in mature cultures. Gene expression levels were normalized to the standard calibrator,
the housekeeping gene 18S rRNA and the mRNA expression at 1 DIV. Data represent mean ± S.E.M. of three independent experiments
performed in duplicates. ∗P<0.05 ∗∗P<0.01 ∗∗∗P<0.001 comparing treated to control (untreated) cultures.
whether the astrocytic toxicity could be a secondary eﬀect
due to the decreased neurotoxicity observed in the presence
of NBQX and APV.
4. Discussion
In this study, we have shown that domoic acid exposure-
induced changes in the mRNA level of selected genes
identiﬁed as speciﬁc markers for glial and neuronal cells in
both developing (immature) and in mature mixed neuronal-
glia cultures of primary rat CGCs. Interestingly, the changes
in mRNA levels indicate that the mature cultures seemed to
be more sensitive to the DomA exposure than the immature
ones. In mature cultures, all neuronal markers (NF-68, NF-
200, NMDA-R, and GABAA-R) were signiﬁcantly and earlier
downregulated afterdomoic acid exposure than in immature
cultures, which indicates a higher vulnerability.
These results suggest that the long-term exposure could
lead to neuronal dysfunction, as the cytoskeleton proteins
(bothNF-68,andNF-200)aswellastheexpressionofcritical
receptors both excitatory (NMDA) and inhibitory (GABA)
were aﬀected. The highest concentration of DomA also
aﬀected glia (decreased expression of GFAP and increased
expression of S100β) that could additionally make neurons
more vulnerable to DomA-induced toxicity. Also, higher
expression of nestin supports the possible presence of
activated astrocytes in response to DomA exposure.
The obtained results indicate that the applied gene
expression tool is sensitive enough to identify cellular
changes at concentrations that are not identiﬁed by cytotox-
icity assays, such as AB used in these studies.
In the previous study by Qiu et al. [9], the obtained
results support our ﬁndings. Indeed, it has been shown
that NMDA receptor could play an important role as an
increase in the excitotoxicity was observed with increasing
in vitro time. This could be due to lower expression of
the glutamate receptors (AMPA/KA and NMDA) in the
younger cultures, which have been proposed to mediate the
excitotoxicity of domoic acid. It has also been proposed that
more Ca2+ permeable AMPA/KA-Rs or AMPA-R isoforms
could be activated in the mature cultures in comparison
to the younger cultures [9], causing glutamate release that
subsequently could activate the NMDA receptor [10, 11]
promoting neurotoxicity.
In our studies, the changes in the expression of the
receptors during development could explain the increased
vulnerability as the mRNA levels of the AMPA-R were
increased approximately ﬁvefold at 3 days and 20-fold at 10
days as compared to the levels at 1 day. In contrast to our
observations, in vivo animal studies have clearly reported
that fetuses and neonates are much more vulnerable to
domoic acid-induced toxicity than adults [1, 3, 4]. The in
vivovulnerability of the immature brain might depend more
on the increased bioavailability of the compound due toJournal of Toxicology 11
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Figure 6: Changes in the mRNA levels of astocytic and precursor markers in mature primary cultures of CGCs exposed to 20μM domoic
acid alone or in combination with antagonists for the AMPA-R (NBQX, 20μM), NMDA-R (APV, 100μM) or the neurotransmitter GABA
(10μM) at 7 DIV for 3 or 10 days. NBQX but not APV or GABA prevented the domoic acid induced downregulation of (a) GFAP mRNA
expression. Note that NBQX, APV and GABA could prevent the domoic acid induced up-regulation of (b) S100β and (c) nestin mRNA
levels. Gene expression levels were normalized to the standard calibrator, the housekeeping gene 18S rRNA and the mRNA expression at
1 DIV. Data represent mean ± S.E.M. of three independent experiments performed in duplicates. ∗P<0.05 ∗∗P<0.01 ∗∗∗P<0.001
comparing treated to control (un-treated) cultures.
incomplete blood brain barrier formation and decreased
serum clearance than the DomA-induced mechanism of
toxicityitself.Thiscouldexplainthecontraryinvitroﬁnding,
w h e r em a t u r ec u l t u r e ss e e mt ob em o r es u s c e p t i b l et h a n
immature ones to DomA-induced neurotoxicity.
The expression of these two receptors (AMPA and
NMDA) should be evaluated in whole animal studies to
make a better comparison between in vitro and in vivo
DomA-induced eﬀects to be able to identify the critical
stages of brain development that are more vulnerable to
domoic acid exposure. Such knowledge would then help to
identify whether a speciﬁc age group might be of greater
risk to domoic acid-induced neurotoxic eﬀects than others.
If DomA toxicity is only mediated through the glutamate
receptors, the lack of these functional receptors during the
ﬁrst DIV would be responsible for lower levels of toxicity
induced by DomA as observed in our studies.
Domoic acid-induced neurotoxicity, in both mature and
immature cultures, seemed to be mediated mainly through
theAMPA/KA-RasNBQXcompletelyreversedthedecreased
mRNA levels for all the selected neuronal markers (NF-68,
NF-200, NMDA-R, and GABAA-R). In contrast, the NMDA-
Rantagonist(APV)couldnotpreventallthechangesofthese
mRNA levels.
In acute in vitro studies (1hr of exposure), it have been
shown that AMPA/KA receptors (not NMDA-R) mediate
low concentration domoic acid- (0.1μM) induced apoptosis,
while a higher concentration (10μM) activates both the
AMPA/KA-R and NMDA receptor leading to necrosis [31].
Interestingly, in this studies, the toxicity of DomA
(changes in the expression of NF-68, NF-200, NMDA-R,
GABAA-R, S100β, and nestin) was reduced in mature culture
by adding external GABA. In vivo studies have shown
reduced expression of the neurotransmitter GABA in the
brain after domoic acid exposure [3, 8, 32] and a similar
decrease could possibly also take place in our in vitro model.
Indeed, local hippocampal administration of GABA in rat in
vivo studies resulted in neuronal protection against DomA-
inducedtoxicity[8]asw ellasinthisinvitrostudy.Moreover,
in our previous in vitro study, we observed that the function
of the GABAA receptor was downregulated after long-term
exposure to DomA, possibly due to lower levels of the
neurotransmitter GABA [33]. In contrast, GABA did not
reduce the toxic eﬀects of domoic acid in immature cultures
perhaps due to the low expression of GABA receptors.
The obtained results also pointed out to the important
role of glia in DomA-induced neurotoxicity. In the previous
studies, including the results obtained by Giordano et al.
[31], pure neuronal cultures were applied, while our exper-
iments were performed using mixed neuronal-glia cultures
(neurons,astrocytes,andmicroglia),andespecially,thepres-
enceofastrocytescouldplayanimportantroleintheDomA-
induced mechanisms of toxicity. This is a critical issue, as
neurons respond diﬀerently to the same toxicant depending12 Journal of Toxicology
on the presence or absence of glia [34]. There are some
reports suggesting that the domoic acid toxicity could be
enhanced in the presence of astrocytes and microglia due to
for instance DomA-induced inhibition of glutamate uptake
by astrocytes [15] followed by glial activation (initially of
microglia and later of astrocytes). Activated microglia and
astrocytes could release neurotoxic free oxygen radicals,
nitric oxide and proinﬂammatory cytokines [16, 35, 36].
Indeed, in mixed neuronal-glia control primary cultures of
CGCs, the proliferation of astrocytes and microglia takes
place over time [18], and DomA-induced increased toxicity
observed in mature cultures could, therefore, be due to a
higher amount of glial cells (both astrocytes and microglia).
The immature cultures (4 DIV) consist of 93 ± 3% neurons,
4 ± 0.3% astrocytes, and 3 ± 0.1% microglia, while the
mature cultures (8–12 DIV) consist of 78 ± 3% neurons,
18 ± 0.8% astrocytes, and 4 ± 0.2% microglia [18].
In our studies, domoic acid clearly aﬀected not only neu-
rons, but also astrocytes as changes in the mRNA expression
of GFAP (downregulation) and S100β (upregulation) was
observed. However, these eﬀects could only be observed in
mature cultures, and the lack of eﬀects in the immature
cultures could be because of low levels of astrocytes.
Moreover, the mature cultures showed a signiﬁcant increase
in the mRNA level of nestin after DomA exposure that has
been reported to be a sensitive marker of activated astrocytes
[37–39].
Decrease in GFAP expression has been associated with
the inhibition of glutamate uptake [40, 41], which indeed
could be the case in our study, as DomA exposure has
shown to decrease uptake of glutamate in astrocytes [15].
In contrast, increased level of S100β is recognized as a
marker of brain damage [42, 43]. While extracellular S100β
at normal concentrations has a neurotrophic eﬀect, higher
concentrations can activate astrocytes and microglia and
induce neuronal cell death [44]. Moreover, S100β has been
linked to diﬀerent brain pathological conditions such as
Alzheimer’s disease [45] and Down’s syndrome [46, 47].
Similarly, the domoic acid-induced upregulation of nestin
mRNA is likely due to glia activation in response to DomA
induced neuronal damage (observed as decreased mRNA for
the neuronal markers) rather than due to the proliferation of
neural precursor cells.
Summing up the obtained results suggests that DomA-
induced neurotoxicity mediated through diverse mecha-
nisms of toxicity in mature and immature cultures could be
identiﬁed by the observed changes in mRNA expression of
diﬀerent cell markers (both neuronal and glial).
Evaluation of gene expression could be a promising
endpoint [17, 18] to be included in an in vitro DNT testing
strategy. Such approach could be useful for an initial identi-
ﬁcation and further prioritization of compounds that might
have DNT potential.
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